Key facts
- Baselake Partners, LP filed SCHEDULE 13G for Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR).
- Disclosed ownership: 5.3%.
- Date of event: 30 Mar 2026.
Baselake Partners, LP - 30 Mar 2026 SCHEDULE 13G Report for Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR)
- Filing Manager
- Baselake Partners, LP
- Reporting Manager
- Baselake Partners, LP
- Symbol
- KZR
- Shares outstanding
- 7,393,623 shares
- Disclosed Ownership
- 391,862 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Apr 2026, 21:28:45 UTC
- Date of event
- 30 Mar 2026
- Next filing
- 12 May 2026
- SEC
- View on sec.gov
Key filing fact
Baselake Partners, LP disclosed 5.3% ownership in Kezar Life Sciences, Inc. Common Stock, $0.001 par value per share (KZR) on 30 Mar 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Apr 2026, 21:28.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baselake Partners, LP | 5.3% | 391,862 | 0 | 391,862 | /s/ David Paolella | David Paolella, Managing Member of Baselake Management, LLC, its investment manager | |
| Baselake Management, LLC | 5.3% | 391,862 | 0 | 391,862 | /s/ David Paolella | David Paolella, Managing Member | |
| David Paolella | 5.3% | 391,862 | 0 | 391,862 | /s/ David Paolella | Individually |
CIK / CUSIP context first